FINANCIAL COUNSELORS INC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 218 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
FINANCIAL COUNSELORS INC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$134,000
+14.5%
10,660
+5.9%
0.00%
+50.0%
Q4 2021$117,000
-27.3%
10,070
-28.6%
0.00%
-50.0%
Q4 2020$161,000
+26.8%
14,1000.0%0.00%0.0%
Q3 2020$127,000
-0.8%
14,100
+13.7%
0.00%0.0%
Q2 2020$128,000
-43.4%
12,400
-44.7%
0.00%
-60.0%
Q1 2020$226,0000.0%22,420
+32.2%
0.01%
+25.0%
Q4 2019$226,000
+59.2%
16,960
+2.4%
0.01%
+33.3%
Q3 2019$142,000
-18.4%
16,560
+4.1%
0.01%
-14.3%
Q2 2019$174,000
-14.7%
15,910
+5.4%
0.01%
-22.2%
Q1 2019$204,00015,1000.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders